Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Division of Hematology/Oncology and Blood and Bone Marrow Transplantation and Cellular Therapy, Mayo Clinic, Jacksonville, FL.
Blood Adv. 2022 Dec 27;6(24):6213-6218. doi: 10.1182/bloodadvances.2022008120.
Participation of women and early-career faculty in hematology and medical oncology board review lecture series has not been studied previously. We aimed to evaluate gender and early-career faculty disparities in hematology and medical oncology board review lecture series. Speakers at major hematology and/or oncology board review lecture series meetings in the United States were analyzed in this cross-sectional study during a 5-year period from the years 2017 through 2021. Data about the lecture topic, field, speaker's gender, years of experience, and the frequency at which the lecture was given by the speaker were collected. Of 386 speakers participating, 315 (81.6%) were ABIM (American Board of Internal Medicine)-certified. A total of 1,224 board review lectures were given in the studied period, of which 1,016 (83%) were given by an ABIM-certified speaker. Women constituted 37.7% of all speakers, with less than 50% representation in five out of six courses. Lectures discussing malignant hematology topics had the lowest proportion of women presenters (24.8%), followed by solid tumors (38.9%) and benign hematology lectures (44.1%). Faculty with more than 15 years since initial certification presented more than 50% of lectures. The median time from initial hematology or medical oncology certification to lecture presentation was 12.5 years and 14 years, respectively. A positive trend in the participation of women was found at all board review conferences across the studied period. Our data suggest that women and early-career faculty participation in hematology and oncology board review series is inadequate.
以前没有研究过女性和初级教职员工在血液学和肿瘤医学董事会审查讲座系列中的参与情况。我们旨在评估血液学和肿瘤医学董事会审查讲座系列中性别和初级教职员工的差异。在这项横断面研究中，分析了美国主要血液学和/或肿瘤学董事会审查讲座会议在 2017 年至 2021 年的 5 年期间的演讲者。收集了关于讲座主题、领域、演讲者的性别、经验年限以及演讲者讲授讲座的频率的数据。在参与的 386 位演讲者中，有 315 位（81.6%）通过了 ABIM（美国内科医师学会）认证。在研究期间共举办了 1224 次董事会审查讲座，其中 1016 次（83%）由 ABIM 认证的演讲者举办。女性占所有演讲者的 37.7%，其中六个课程中有五个课程的代表人数不到 50%。讨论恶性血液病主题的讲座中女性演讲者的比例最低（24.8%），其次是实体肿瘤（38.9%）和良性血液病讲座（44.1%）。拥有超过 15 年初始认证的教职员工主讲了超过 50%的讲座。从最初的血液学或肿瘤学认证到讲座演讲的中位数时间分别为 12.5 年和 14 年。在整个研究期间，所有董事会审查会议的女性参与度都呈现出积极的趋势。我们的数据表明，女性和初级教职员工在血液学和肿瘤学董事会审查系列中的参与度不足。
